PLSE's logo.
Ticker Symbol: PLSE

Pulse Biosciences Inc

$21.58 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001625101

Company Profile

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company's proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 3957 Point Eden Way
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $4.05
Change: - ( 0.00%)
Days Range: $4.01 - $4.18
Beta: 1.04
52wk. High: $9.69
52wk. Low: $1.65
Ytd. Change 46.57%
50 Day Moving Average: $4.30
200 Day Moving Average: $6.10
Shares Outstanding: 54902942

Valuation

Market Cap: 22.3B
PE Ratio: -3.38
EPS (TTM): -1.2

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A